Your browser doesn't support javascript.
loading
EGFR-RAD51 fusion variant in lung adenocarcinoma and response to erlotinib: A case report.
Zhu, You-Cai; Wang, Wen-Xian; Xu, Chun-Wei; Song, Zheng-Bo; Du, Kai-Qi; Chen, Gang; Lv, Tang-Feng; Song, Yong.
Afiliação
  • Zhu YC; Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang 314000, People's Republic of China.
  • Wang WX; Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, People's Republic of China. Electronic address: helen-0407@163.com.
  • Xu CW; Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, People's Republic of China. Electronic address: xuchunweibbb@163.com.
  • Song ZB; Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, People's Republic of China.
  • Du KQ; Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang 314000, People's Republic of China.
  • Chen G; Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, People's Republic of China.
  • Lv TF; Department of Respiratory Medicine, Jinling Hospital, Nanjing, Jiangsu 210002, People's Republic of China.
  • Song Y; Department of Respiratory Medicine, Jinling Hospital, Nanjing, Jiangsu 210002, People's Republic of China.
Lung Cancer ; 115: 131-134, 2018 01.
Article em En | MEDLINE | ID: mdl-29290255

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Fusão Oncogênica / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Rad51 Recombinase / Cloridrato de Erlotinib / Neoplasias Pulmonares / Mutação / Antineoplásicos Tipo de estudo: Guideline Limite: Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Fusão Oncogênica / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Rad51 Recombinase / Cloridrato de Erlotinib / Neoplasias Pulmonares / Mutação / Antineoplásicos Tipo de estudo: Guideline Limite: Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article
...